MedSchool: Ace Your OSCEsThe Medical Company
GET - On the App Store
Drug Guide


    Oral / IV

  • Mechanism of Action

  • Converted intracellularly into diphosphate and triphosphate forms. The diphosphate form inhibits ribonucleotide reductase resulting in reduced intracellular deoxynucleotides, while the triphosphate form is incorporated into DNA and disrupts DNA polymerase activity.

Clinical Use

  • Indications

  • Certain haematologic organ malignancies, as guided by cancer specialists and local guidelines.
  • Adverse Effects
  • Bone marrow suppression - leucopaenia / thrombocytopaenia / anaemia
  • Anxiety
  • Tachycardia
  • Headache / dizziness
  • Nausea / vomiting / anorexia / diarrhoea
  • Arthralgia / myalgia
Want more info like this?
  • Your electronic clinical medicine handbook
  • Guides to help pass your exams
  • Tools every medical student needs
  • Quick diagrams to have the answers, fast
  • Quizzes to test your knowledge
Sign Up Now

Snapshot: Initialising...